ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GA20271-005mg |
|
97773-00-7 |
(Phe²,Nle⁴)-ACTH (1-24) (human, bovine, rat)
|
0 | C137H212N40O30 | |
GA20270-1mg |
|
160201-86-5 |
(Phe¹³,Tyr¹⁹)-MCH (human, mouse, rat)
|
0 | C109H160N30O26S4 | |
GA20270-005mg |
|
160201-86-5 |
(Phe¹³,Tyr¹⁹)-MCH (human, mouse, rat)
|
0 | C109H160N30O26S4 | |
GA20269-5mg |
|
473902-31-7 |
(Pen⁵)-Urotensin II (4-11) (human)
|
0 | C52H68N10O12S2 | |
GA20269-1mg |
|
473902-31-7 |
(Pen⁵)-Urotensin II (4-11) (human)
|
0 | C52H68N10O12S2 | |
GA20268-25mg |
|
— |
(Orn(Atosiban (free acid))⁸)-Atosiban
|
0 | C86H131N21O24S4 | |
GA20267-25mg |
|
— |
(Orn(Ac)⁸)-Atosiban
|
0 | C45H69N11O13S2 | |
GA20266-1mg |
|
103613-84-9 |
(N-Me-Tyr¹,N-Me-Arg⁷,D-Leu-NHEt⁸)-Dynorphin A (1-8)
|
0 | C50H81N15O9 | |
GA20266-005mg |
|
103613-84-9 |
(N-Me-Tyr¹,N-Me-Arg⁷,D-Leu-NHEt⁸)-Dynorphin A (1-8)
|
0 | C50H81N15O9 | |
GA20265-5mg |
|
110880-53-0 |
(N-Me-Phe⁷)-Neurokinin B
|
0 | C60H81N13O14S2 | |
GA20265-1mg |
|
110880-53-0 |
(N-Me-Phe⁷)-Neurokinin B
|
0 | C60H81N13O14S2 | |
GA20264-1mg |
|
71539-01-0 |
(Nle⁸·¹⁸,Tyr³⁴)-pTH (7-34) amide (bovine)
|
0 | C158H248N48O49 | |
GA20264-005mg |
|
71539-01-0 |
(Nle⁸·¹⁸,Tyr³⁴)-pTH (7-34) amide (bovine)
|
0 | C158H248N48O49 | |
GA20263-1mg |
|
64297-16-1 |
(Nle⁸·¹⁸,Tyr³⁴)-pTH (3-34) amide (bovine)
|
0 | C177H279N53O48 | |
GA20263-005mg |
|
64297-16-1 |
(Nle⁸·¹⁸,Tyr³⁴)-pTH (3-34) amide (bovine)
|
0 | C177H279N53O48 | |
GA20262-1mg |
|
64763-77-5 |
(Nle⁸·¹⁸,Tyr³⁴)-pTH (1-34) amide (bovine)
|
0 | C185H293N55O50 | |
GA20262-005mg |
|
64763-77-5 |
(Nle⁸·¹⁸,Tyr³⁴)-pTH (1-34) amide (bovine)
|
0 | C185H293N55O50 | |
GA20261-1mg |
|
78041-34-6 |
(Nle⁸·¹⁸,Tyr³⁴)-pTH (1-34) (human)
|
0 | C183H295N55O52 | |
GA20261-005mg |
|
78041-34-6 |
(Nle⁸·¹⁸,Tyr³⁴)-pTH (1-34) (human)
|
0 | C183H295N55O52 | |
GA20260-1mg |
|
1802086-51-6 |
(Nle³⁵)-Amyloid β-Protein (1-42)
|
0 | C204H313N55O60 | |